Orotidine 5 0 -monophosphate (OMP) decarboxylase (OMPDC; EC 4.1.1.23) catalyzes the final step in the de novo synthesis of uridine 5 0 -monophosphate (UMP) and defects in the enzyme are lethal in the malaria parasite Plasmodium falciparum. Active recombinant P. falciparum OMPDC (PfOMPDC) was crystallized by the seeding method in a hanging drop using PEG 3000 as a precipitant. A complete set of diffraction data from a native crystal was collected to 2.7 Å resolution at 100 K using synchrotron radiation at the Swiss Light Source. The crystal exhibits trigonal symmetry (space group R3), with hexagonal unit-cell parameters a = b = 201.81, c = 44.03 Å . With a dimer in the asymmetric unit, the solvent content is 46% (V M = 2.3 Å 3 Da À1 ).
Introduction
There are an estimated 300-500 million cases of malaria and up to three million people die from this disease annually. Plasmodium falciparum is the causative agent of the most lethal and severe form of human malaria (Guerin et al., 2002) . Chemotherapy of malaria is available, but is complicated by both adverse effects and widespread resistance to most of the currently available antimalarial drugs (Attaran et al., 2004; White, 2004) . More efficacious and less toxic agents that uniquely target the parasite are therefore required.
The malaria parasite depends on de novo synthesis of pyrimidine nucleotides, whereas the human host has the ability to synthesize them by both de novo and salvage pathways (Krungkrai et al., 1990; Jones, 1980; Weber, 1983) . The final two steps of uridine 5 0 -monophosphate (UMP) synthesis require the addition of ribose 5-phosphate from 5-phosphoribosyl-1-pyrophosphate (PRPP) to orotate by orotate phosphoribosyltransferase (OPRT; EC 2.4.2.10) to form orotidine 5 0 -monophosphate (OMP) and the subsequent decarboxylation of OMP to form UMP by OMP decarboxylase (OMPDC; EC 4.1.1.23). Both enzymes are encoded by two separate genes in most prokaryotes and the malaria parasite (Krungkrai et al., 2003; Krungkrai, Aoki et al., 2004) , whereas their genes in most multicellular organisms, including humans, are fused into a single gene, resulting in the bifunctional UMP synthase (Livingstone & Jones, 1987; Suttle et al., 1988; Suchi et al., 1997) . Our recent studies have demonstrated that the two enzymes exist as a heterotetrameric (OPRT) 2 (OMPDC) 2 complex in two species of malaria parasites, P. falciparum and P. berghei (Krungkrai, Prapunwattana et al., 2004; Krungkrai et al., 2005) . By multiple sequence-alignment analysis, the protein sequence of P. falciparum OMPDC was found to be less than 20% identical to both the human enzyme (Suttle et al., 1988) and the four bacterial and yeast OMPDCs for which crystal structures are known, i.e. Bacillus subtilis (Appleby et al., 2000) , Escherichia coli (Harris et al., 2000) , Methanobacterium thermoautotrophicum (Wu et al., 2000) and Saccharomyces cerevisae (Miller et al., 2000) . The low sequence identities make it difficult to build a homology model for P. falciparum OMPDC. However, the low similarity between the enzymes of the host and the pathogen mean that OMPDC has promise as a drug target. In addition, OMPDC is known to be an unusually proficient catalyst (Miller & Wolfenden, 2002) . These facts have prompted us to perform crystallization and X-ray diffraction analysis of the monofunctional P. falciparum OMPDC (PfOMPDC) expressed in E. coli. Here, we report the conditions for expression, purification, crystallization and preliminary crystallographic analysis of the uncomplexed apo form of PfOMPDC.
Experimental

Protein expression and purification
The recombinant OMPDC protein was prepared by cloning and expression of the gene encoding PfOMPDC in E. coli. The oligonucleotide primers were 5 0 -CGG GAT CCA TGG GTT TTA AGG TAA AAT TA-3 0 and 5 0 -CCA TCG ATT TAC GAT TCC ATA TTT TGC TTT AA-3 0 , which encompass BamHI and ClaI restriction sites (in bold), respectively. The polymerase chain reaction was carried out using P. falciparum cDNA as a template and Pfu DNA polymerase (Promega) at 368 K for 5 min, followed by 40 cycles of 368 K for 1 min, 328 K for 1 min and 341 K for 3 min and finally an additional 341 K for 10 min. The PCR-derived fragment of $980 bp complete PfOMPDC was inserted into the expression vector pTrcHis-TOPO (Invitrogen) linearized with BamHI and ClaI. E. coli TOP10 (Invitrogen) cells were transformed with the recombinant plasmid and induced with 1 mM isopropyl -d-thiogalactopyranoside at 291 K for 18-20 h and the cell paste was then harvested by centrifugation at 8000g for 10 min. The recombinant enzyme was expressed as a soluble protein and purified using an Ni 2+ -nitrilotriacetic acidagarose affinity column (Qiagen) with 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 250 mM imidazole and 10% glycerol as the elution buffer. The recombinant protein was further purified by AKTA fast protein liquid chromatography using a Superdex-75 HiLoad 26/60 column (Amersham Biosciences) equilibrated with 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 5 mM dithiothreitol. The enzyme activity was eluted as a single symmetrical peak at a position corresponding to 76 kDa. SDS-PAGE analysis (Laemmli, 1970) showed a homogenous preparation with a molecular weight of 38 kDa, suggesting that the active form of the PfOMPDC is a dimer. The OMPDC activity was monitored by the decrease in the absorbance of OMP at 285 nm according to a previously described method (Yablonski et al., 1996) . The purified recombinant enzyme had a specific activity of approximately 10 mmol min À1 per milligram of protein, corresponding to a 300-fold purification and 30% yield. Up to 30 mg of the pure recombinant protein was obtained from 10 l E. coli cell culture. The purified protein was concentrated by Centricon ultrafiltration to 10 mg ml À1 and the homogeneity was confirmed by dynamic light scattering using a DynaPro-MS/X (Protein Solutions Inc.).
Crystallization of PfOMPDC
Purified PfOMPDC in 50 mM Tris-HCl pH 8.0 buffer containing 300 mM NaCl and 5 mM dithiothreitol was concentrated to 10 mg ml À1 . Crystallization of PfOMPDC was first performed using the sitting-drop vapour-diffusion method at 293 K with the semi- Crystals of OMPDC from P. falciparum. Thin crystals were obtained in the first crystallization trial in a sitting drop (a); however, the quality of the crystals was improved by using the seeding method in a hanging drop (b).
Figure 2
X-ray diffraction image from a OMPDC crystal. The frame edge in the close-up is 2.7 Å . sampling method (Jancarik & Kim, 1991) using Crystal Screens I and II (Hampton Research) and Wizard Screens I and II (Emerald BioStructures) in 96-well sitting-drop plates (Corning) at 293 K. The drop size was 1 ml protein solution (10 mg ml À1 ) plus 1 ml of one of the precipitating reagents. The reservoir contained 0.2 ml of the same reagent. From the 200 crystallization conditions, needle-shaped crystals with maximum dimensions of 0.03 Â 0.03 Â 1.2 mm appeared in the drops using Crystal Screen II solutions No. 30 [10% PEG 6K, 0.1 M HEPES pH 7.5, 5% 2-methyl-2,4-pentanediol (MPD)] and No. 37 (10% PEG 8K, 0.1 M HEPES pH 7.5, 8% ethylene glycol) and Wizard Screen I solution No. 41 (30% PEG 3K, 0.1 M CHES pH 9.5) within 2 d at 293 K (Fig. 1) . While the crystals that appeared from Crystal Screen II solutions No. 30 and No. 37 were fragile, those from Wizard Screen II solution No. 41 were suitable for X-ray crystallographic studies after size improvement by the seeding method using 13%(w/v) and 18%(w/v) PEG 3K solutions for the sitting drop and the mother liquor, respectively.
Data collection and processing
X-ray diffraction data were collected from a single crystal of PfOMPDC on the X06SA beamline at the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland). Prior to data collection, the crystal of PfOMPDC was soaked in a cryoprotectant solution consisting of 18%(w/v) PEG 3K, 0.1 M CHES pH 9.5, 8% MPD. The crystal of PfOMPDC was then mounted in a standard nylon loop in a stream of cold nitrogen gas at 100 K. The diffraction patterns were recorded on a MAR CCD detector (MAR USA) at cryogenic temperature (100 K). The wavelength, crystal-to-detector distance, oscillation range and exposure time were 0.978 Å , 250 mm, 1.0 and 1 s, respectively. A complete data set was collected from 200 images covering 200 in total (Fig. 2) .
The diffraction intensity data were processed and scaled using MOSFLM (Leslie, 1992) . The crystal of PfOMPDC is trigonal, belonging to space group R3, with unit-cell parameters a = b = 201.81, c = 44.03 Å . From the 451 733 accepted observations to 2.7 Å resolution, 18 313 unique reflections were obtained. The statistics of the diffraction data are shown in Table 1 .
The self-rotation function calculated with the program POLARRFN from the CCP4 program package (Collaborative Computational Project, Number 4, 1994) suggested that two PfOMPDC molecules correlated by a non-crystallographic twofold axes were present in the asymmetric unit (Fig. 3) , giving a Matthews coefficient of 2.3 Å 3 Da À1 and a solvent content of 46%.
Preliminary molecular-replacement calculations were performed with the program AMoRe (Navaza, 2001) from the CCP4 program package (Collaborative Computational Project, Number 4, 1994) using the structure of OMPDC from B. subtilis (PDB code 1dbt) as the search model (Appleby et al., 2000) . Since the identity of the amino-acid sequences between PfOMPDC and B. subtilis OMPDC is only 16%, MAD data collection using SeMet-derivative crystals was attempted. During the phase calculation using the anomalous dispersion signal, the crystal structure of OMPDC from P. vivax was deposited in the PDB (PDB code 2ffc). The deposited structure is that of a complex with UMP, demonstrating a product-binding form. The space group of the crystal is P2 1 2 1 2, in contrast to the crystal reported here, which belongs to space group R3. The molecularreplacement method using this structure and a structural comparison between the apo and holo forms are in progress.
Figure 3
Stereographic projections of the self-rotation function calculated in the = 180 section. The resolution of the data used was 15.0-2.7 Å . The X-ray data were reduced in a trigonal crystal system using a hexagonal cell. 12 peaks were clearly obtained in the calculated self-rotation map, suggesting that a non-crystallographic twofold axis exists in the asymmetric unit. Table 1 Crystal parameters and X-ray diffraction data-collection statistics.
Values in parentheses are for the highest resolution shell (2.85-2.70 Å ).
Crystal system
Trigonal with hexagonal unit cell Space group 12.4 (4.0) † R merge = P jIðkÞ À Ij= P IðkÞ, where I(k) is value of the kth measurement of the intensity of a reflection, I is the mean value of the intensity of that reflection and the summation is over all measurements.
